Information on the target
Whitestone, a holding company based in Lasne, Belgium, reported an intrinsic value close to its current stock price as of the end of June. This positions Whitestone as an exception within the small universe of Belgian holding companies. As of June, the holding company had an intrinsic value of €190 million, reflecting a significant increase of 47% compared to the end of December. The semi-annual results, which are disclosed later due to the company's listing on Euronext Growth, indicate a market capitalization of €173 million, with shares trading at €17.30, representing a limited discount to its intrinsic value of €18.4 per share.
Founded by former collaborators of the Compagnie Nationale à Portefeuille (CNP) of the Frère family, Whitestone went public in 2021 through the acquisition of the now-defunct Walloon printing company Evadix. Gérard Lamarche, the former co-CEO of GBL, the Frère holding company, serves as its president. The increase in intrinsic value is primarily attributed to a capital increase of €54 million, alongside a positive portfolio return of 5.5%. In October, Whitestone divested its entire stake in the sand giant Sibelco, which is expected to further enhance its intrinsic value by 2%.
Industry overview in the target’s specific country
The Advanced Medical Equipment & Technology (NEC) industry in Belgium is characterized by a robust framework of innovation and regulatory support, positioning the country as a leader in healthcare technology within Europe. Belgium's strategic location, combined with its highly skilled workforce and strong research institutions, fosters a conducive environment for the development and commercialization of advanced medical technologies. The sector has seen substantial investment in recent years, driven by increasing demand for innovative healthcare solutions and a growing emphasis on patient-centered care.
Belgium's healthcare system is among the best in Europe, with a strong emphasis on integrating advanced medical technologies into clinical practice. The government actively supports the adoption of new technologies through various funding programs and incentives aimed at enhancing healthcare delivery. This has led to a flourishing ecosystem of startups and established companies focused on developing cutting-edge medical devices and equipment, particularly in areas such as diagnostics, imaging, and minimally invasive surgical technologies.
Moreover, the Belgian market benefits from a collaborative approach between public and private sectors, which has resulted in successful partnerships between healthcare providers, technology developers, and academic institutions. This synergy not only accelerates innovation but also ensures that new technologies are aligned with the needs of healthcare professionals and patients alike. As a result, the Advanced Medical Equipment & Technology sector is poised for continued growth, driven by advancements in technology and an increasing focus on improving patient outcomes.
In summary, the Advanced Medical Equipment & Technology industry in Belgium is thriving, supported by a favorable regulatory environment, strong inves…